H.C. Wainwright assists with sale of 8 million common shares at $1.50
By Devika Patel
Knoxville, Tenn., Jan. 30 – InVivo Therapeutics Holdings Corp. said it will conduct a $12 million registered direct offering of shares.
The company will sell 8 million common shares at $1.50 per share. The price per share reflects a 31.51% discount to the Jan. 28 closing share price of $2.19.
H.C. Wainwright & Co. is the agent.
Settlement is expected Thursday.
Proceeds will be used for general corporate purposes.
Based in Cambridge, Mass., the company is focused on technologies for spinal cord injuries.
| Issuer: | InVivo Therapeutics Holdings Corp.
|
| Issue: | Common shares
|
| Amount: | $12 million
|
| Shares: | 8 million
|
| Price: | $1.50
|
| Warrants: | No
|
| Agents: | H.C. Wainwright & Co.
|
| Pricing date: | Jan. 29
|
| Settlement date: | Jan. 29
|
| Stock symbol: | OTCBB: NVIV
|
| Stock price: | $2.19 at close Jan. 28
|
| Market capitalization: | $187.62 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
